Back
Maze Therapeutics Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
MAZE
Maze Therapeutics Inc.
Last Price:
$13.22
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and MAZE is experiencing slight selling pressure.
Maze Therapeutics Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.91 | Sell |
| 20-day SMA: | 15.39 | Sell |
| 50-day SMA: | 14.02 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 13.15 | Buy |
| 20-day EMA: | 9.86 | Buy |
| 50-day EMA: | 5.43 | Buy |
| 200-day EMA: | 1.62 | Buy |
Maze Therapeutics Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.55 | Buy |
| Relative Strength Index (14 RSI): | 43.21 | Sell |
| Chaikin Money Flow: | -111078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.12 - 16.8) | Sell |
| Bollinger Bands (100): | (9.2 - 14.56) | Buy |
Maze Therapeutics Inc. Technical Analysis
| Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Maze Therapeutics Inc. Stock
Is Maze Therapeutics Inc. Stock a Buy?
-
Maze Therapeutics Inc. share price is 13.60 while MAZE 8-day simple moving average is 13.91, which is a Sell signal.
-
The stock price of MAZE is 13.60 while Maze Therapeutics Inc. 20-day SMA is 15.39, which makes it a Sell.
-
Maze Therapeutics Inc. 50-day simple moving average is 14.02 while MAZE share price is 13.60, making it a Sell technically.
-
MAZE stock price is 13.60 and Maze Therapeutics Inc. 200-day simple moving average is 0.00, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
14
Maze Therapeutics Inc. (MAZE)
is a Sell
Is Maze Therapeutics Inc. a Buy or a Sell?
-
Maze Therapeutics Inc. stock is rated a SellThe current Maze Therapeutics Inc. [MAZE] share price is $13.60. The Score for MAZE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics Inc. Stock Info
Market Cap:
579M
Price in USD:
13.60
Share Volume:
299.1K
Maze Therapeutics Inc. 52-Week Range
52-Week High:
19.19
52-Week Low:
6.71
Sell
14
Maze Therapeutics Inc. (MAZE)
is a Sell
Maze Therapeutics Inc. Share Price Forecast
-
What is the Maze Therapeutics Inc. stock price today?The Maze Therapeutics Inc. stock price is 13.60 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics Inc. is overvalued.
Is Maze Therapeutics Inc. Stock a Buy?
-
Maze Therapeutics Inc. share price is 13.60 while MAZE 8-day exponential moving average is 13.15, which is a Buy signal.
-
The stock price of MAZE is 13.60 while Maze Therapeutics Inc. 20-day EMA is 9.86, which makes it a Buy.
-
Maze Therapeutics Inc. 50-day exponential moving average is 5.43 while MAZE share price is 13.60, making it a Buy technically.
-
MAZE stock price is 13.60 and Maze Therapeutics Inc. 200-day simple moving average is 1.62, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics Inc.
Is Maze Therapeutics Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.32 per share, an increase this year of $16.89 per share, and a decrease next year of $0.22 per share.
Technical Analysis of Maze Therapeutics Inc.
Should I short Maze Therapeutics Inc. stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is 3.55, suggesting Maze Therapeutics Inc. is a Buy
-
Maze Therapeutics Inc. Relative Strength Index (RSI) is 43.21, which suggest Maze Therapeutics Inc. is oversold
-
The Bollinger Bands (25) for Maze Therapeutics Inc. is (14.12 - 16.8), which suggest Maze Therapeutics Inc. is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics Inc. is (9.2 - 14.56), which suggest Maze Therapeutics Inc. is a Buy
* Maze Therapeutics Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.